Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients
Jae-Ho Yoon, Jong-Wook Kim, Young-Woo Jeon, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park, Seok-Goo Cho
Korean J Intern Med. 2015;30(3):362-371. Published online 2015 Apr 29 DOI: https://doi.org/10.3904/kjim.2015.30.3.362
Citations to this article as recorded by 
The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma
Aleksei K. Koviazin, Larisa V. Filatova, Ilia S. Zyuzgin, Anna S. Artemyeva, Ilia L. Poliatskin, Darya S. Burda, Stanislav A. Volchenkov, Svetlana S. Elkhova, Tatiana Yu. Semiglazova
Cancer Reports.2023;[Epub] CrossRef
Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients
Youngwoo Jeon, Tong-Yoon Kim, Gi June Min, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Hee-Je Kim, Seok Lee, Chang-Ki Min, Jong-Wook Lee, Seok-Goo Cho
Cytotherapy.2023; 25(12): 1307. CrossRef
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
Gi-June Min, Young-Woo Jeon, Tong Yoon Kim, Daehun Kwag, Byung-Su Kim, Joonyeop Lee, Jong Hyuk Lee, Sung-Soo Park, Silvia Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Jong Wook Lee, Seok-Go
Scientific Reports.2023;[Epub] CrossRef
High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell Lymphoma
Qin Wen, Li Gao, Jing-kang Xiong, Qiong Li, San-bin Wang, Ji-shi Wang, Fang Liu, Cheng Zhang, Yao Liu, Pei-yan Kong, Xian-gui Peng, Jun Rao, Lei Gao, Xi Zhang
Current Medical Science.2021; 41(3): 465. CrossRef
Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal abnormalities, despite aggressive treatment
Gi-June Min, Young-Woo Jeon, Sung-Soo Park, Seung-Hawn Shin, Seung-Ah Yahng, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Hee-Je Kim, Chang-Ki Min, Dong-Wook Kim, Jong-Wook Lee, Seok-Goo Cho
Annals of Hematology.2020; 99(3): 557. CrossRef
Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis
Shu-Yun Ma, Xiao-Peng Tian, Jun Cai, Guang-Zheng Zhong, Xu Chen, Hui-Qiang Huang, Tong-Yu Lin, Zhi-Ming Li, Qing-Qing Cai
Annals of Hematology.2020; 99(6): 1311. CrossRef
A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation
Xiaojian Liu, Ting Deng, Xianzhi Guo, Ye Guo, Leiping Wang, Jian Zhang, Zuguang Xia, Quanling Zhang, Kai Xue, Junning Cao, Jumei Shi, Xiaonan Hong
Hematology.2017; 22(5): 258. CrossRef
Prognostic analysis of DLBCL patients and the role of upfront ASCT in high-intermediate and high-risk patients
Ying Zhao, Hong Wang, Song Jin, Jiajia Zheng, Man Huang, Yaqiong Tang, Zhengming Jin, Huiying Qiu, Xiaowen Tang, Chengcheng Fu, Yue Han, De-Pei Wu
Oncotarget.2017; 8(42): 73168. CrossRef
Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation
Hong Ghi Lee, Sung-Yong Kim, Inho Kim, Yeo-Kyeoung Kim, Jeong-A Kim, Yang Soo Kim, Ho Sup Lee, Jinny Park, Seok Jin Kim, Hyeok Shim, Hyeon Seok Eom, Byeong-Bae Park, Junglim Lee, Sung Kyu Park, June-Won Cheong, Keon Woo Park
Blood Research.2015; 50(3): 160. CrossRef